OTC Glucose Sensing

Podcast Episode 27: How Dexcom Real-Time CGM Supports Pregnant Patients and Enhances Diabetes Management

Podcasts

Yes

Related Resources

Podcast Episode 26: Type 2 Diabetes Management with CGM (ATTD)

Premium Content

Off

ADCES 2025 - Evidence of Impact: Validating the Behavioral Approach

alexa.stelzer — Tue, 02 Sep 2025 18:36:32 +0000

ADCES 2025 - Evidence of Impact: Validating the Behavioral Approach

09/12/2025

alexa.stelzer Tue, 09/02/2025 - 18:36

Presented August 8, 2025

Empowering Behavior Change in Metabolic Health: How Stelo by Dexcom Supports a Person-Centered Approach

Segment 3: Evidence of Impact: Validating the Behavioral Approach

Event: ADCES25 - Sponsored by Association of Diabetes Care & Education Specialists (ADCES)

Location: Phoenix, AZ

Date: August 8, 2025

Speaker: Maggie Crawford, PhD, MPH, Sr Manager Data Science at Dexcom

Session Overview:

In this 14-minute video, Dr. Maggie Crawford presents the third of three segments in the "Empowering Behavior Change in Metabolic Health" session, introducing Dexcom's Quantitative Research Team and the behavioral science evidence supporting Stelo.

Video Timestamps:

[01:34] Dexcom's Quantitative Research Team
[02:11] Behavioral Science Evidence
[03:39] Real-World Dexcom CGM Use in T2D NIT Evidence
[07:12] Early Experiences with Stelo Evidence
[12:48] Takeaways

Watch the first two segments from this session:

Segment 1: Why Behavioral Science for HCPs?
Segment 2: Understanding Behavior Maps: Turning Data Into Action

^{This is a recording of a live presentation. The information you see or hear at this event provides details about medical products which are not available in all countries, may have different indications, and/or have not received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing shown or stated herein should be construed as a solicitation, advertisement, or promotion of any product, or of an indication of any specific use for any product, which is not authorized by the laws and regulations of the country where you reside.}

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^MAT-10691

ADCES 2025 - Why Behavioral Science for HCPs?

Yes

Related Resources

ADCES 2025 - Understanding Behavior Maps: Turning Data Into Action

Premium Content

Off

ADCES 2025 - Understanding Behavior Maps: Turning Data Into Action

alexa.stelzer — Tue, 02 Sep 2025 17:29:18 +0000

ADCES 2025 - Understanding Behavior Maps: Turning Data Into Action

09/12/2025

alexa.stelzer Tue, 09/02/2025 - 17:29

Presented August 8, 2025

Empowering Behavior Change in Metabolic Health: How Stelo by Dexcom Supports a Person-Centered Approach

Segment 2: Understanding Behavior Maps: Turning Data Into Action

Event: ADCES25 - Sponsored by Association of Diabetes Care & Education Specialists (ADCES)

Location: Phoenix, AZ

Date: August 8, 2025

Speaker: Siddharth Menon, MS, Data Scientist, Dexcom

Session Overview:

In this 12-minute video, Siddharth Menon presents the second of three segments in the "Empowering Behavior Change in Metabolic Health" session, explaining how behavior maps are used to develop and design Stelo features.

Video Timestamps:

[00:53] Why Behavioral Mapping Matters
[02:20] Definition of Key Terms
[03:45] What is a Behavior Map?
[05:38] Case Study: Spike Detection
[10:59] Support Between Appointments

Watch additional segments from this session:

Segment 1: Why Behavioral Science for HCPs?
Segment 3: Evidence of Impact: Validating the Behavioral Approach

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^MAT-10689

ADCES 2025 - Why Behavioral Science for HCPs?

Yes

Related Resources

ADCES 2025 - Evidence of Impact: Validating the Behavioral Approach

Premium Content

Off

ADCES 2025 - Why Behavioral Science for HCPs?

alexa.stelzer — Tue, 02 Sep 2025 16:52:10 +0000

ADCES 2025 - Why Behavioral Science for HCPs?

09/12/2025

alexa.stelzer Tue, 09/02/2025 - 16:52

Presented August 8, 2025

Empowering Behavior Change in Metabolic Health: How Stelo by Dexcom Supports a Person-Centered Approach

Segment 1: Why Behavioral Science for HCPs?

Event: ADCES25 - Sponsored by Association of Diabetes Care & Education Specialists (ADCES)

Location: Phoenix, AZ

Date: August 8, 2025

Speaker: Harsimran (Sim) Singh, PhD, MA, Behavioral Informatics Lead, Dexcom

Session Overview:

In this 15-minute video, Sim Singh presents the first of three segments in the "Empowering Behavior Change in Metabolic Health" session, exploring how Dexcom places behavior change at the center of innovation in metabolic health with Stelo.

Video Timestamps:

[02:58] Key takeaway: Small nudges change clinic visits
[03:35] Behavioral Science in Diabetes Care
[08:23] Dexcom's Commitment to Behavioral Science
[12:32] Why Stelo?

This segment laid the groundwork for two additional presentations:

Segment 2: Understanding Behavior Maps: Turning Data Into Action
Segment 3: Evidence of Impact: Validating the Behavioral Approach

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^MAT-10688

ADCES 2025 - Understanding Behavior Maps: Turning Data Into Action

Yes

Related Resources

ADCES 2025 - Evidence of Impact: Validating the Behavioral Approach

Premium Content

Off

Podcast Episode 24: Type 2 Diabetes Management Through Glucose Tracking

alexa.stelzer — Mon, 10 Mar 2025 19:35:23 +0000

Podcast Episode 24: Type 2 Diabetes Management Through Glucose Tracking

03/19/2025

alexa.stelzer Mon, 03/10/2025 - 19:35

How CGM Improves Patient Outcomes

Guest Speakers: Dr. Thomas Grace & Dr. William Polonsky

Real-time real talk is intended for healthcare professionals in the US.

In this episode of Real Time Real Talk, host Cher Pastore is joined by Dr. Thomas Grace and Dr. William Polonsky to discuss the power of continuous glucose monitoring (CGM) in managing type 2 diabetes. The discussion includes:

Recent research on patient outcomes with the use of CGM
Benefits of CGM for making informed dietary and lifestyle choices
Psychological effects of CGM use
Introduction of Dexcom's over-the-counter product, Stelo

To learn more about Stelo, visit www.Stelo.com .

^MAT-8098

Podcast

Diabetes Technology

Stelo: Personalizing Choices, Revolutionizing Glucose Health

Podcasts

Yes

Thomas Grace, MD, CDCES

Thomas Grace is a Family Medicine doctor in Findlay, Ohio. Dr. Grace and is rated as a Distinguished doctor by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 2 other conditions, according to our data. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Sepsis, Type 1 Diabetes (T1D), and Pacemaker Implantation.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 1 clinical trial in the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Type 2 Diabetes (T2D).

William H. Polonsky, PhD, CDCES

Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, the world's first organization wholly dedicated to studying and addressing the unmet psychological needs of people with diabetes. He is also Associate Clinical Professor in Psychiatry at the University of California, San Diego. Dr. Polonsky received his PhD in clinical psychology from Yale University and has served as Senior Psychologist at the Joslin Diabetes Center in Boston, faculty member at Harvard Medical School and Chairman of the National Certification Board for Diabetes Educators.

Related Resources

Podcast Episode 23: Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes

Premium Content

Off

Stelo: Personalizing Choices, Revolutionizing Glucose Health Presented by Patrick Welch, PharmD, BCACP

alexa.stelzer — Thu, 20 Feb 2025 15:48:55 +0000

Stelo: Personalizing Choices, Revolutionizing Glucose Health Presented by Patrick Welch, PharmD, BCACP

03/13/2025

alexa.stelzer Thu, 02/20/2025 - 15:48

About the Webinar

In this 43-minute session, Patrick Welch, PharmD, BCACP, provides an introduction to Stelo and key takeways for pharmacists and other healthcare providers.

Key Highlights:

[1:27] The Dexcom portfolio: Discover the differences between Dexcom G7 CGM and Stelo and how to choose the right product for your patients

[7:16] Glucose management matters: Explore why managing glucose levels is important for patients with type 2 diabetes and prediabetes

[13:14] Introducing Stelo: Learn about the innovative functionality of Stelo

[15:47] Case Study: Explore how Stelo impacts decision making and outcomes in a patient with type 2 diabetes

[17:18] Key Stelo features: Deep dive into Stelo's unique features and how they promote behavior change

[33:09] Emerging clinical evidence in T2D: Review recent evidence exploring how glucose monitoring can improve diabetes outcomes

[39:12] Getting started: Learn how to help patients get started on Stelo

About Stelo by Dexcom

Stelo marks a significant advancement in glucose monitoring. As the first FDA-cleared OTC glucose biosensor, it provides an option for those who do not have insurance coverage for CGM. With Stelo, patients can monitor their glucose levels and time spent in their target range, enabling informed decisions about their health and lifestyle.

Learn More About Stelo

Don’t miss out on this valuable opportunity to enhance your practice and improve patient care. Learn more at Stelo.com.

^Keywords^{: Stelo, glucose biosensor, glucose monitoring, prediabetes, type 2 diabetes, Dexcom, patient empowerment, primary care, glucose health webinar}
^MAT-7831

New Video Series: Your Journey with Stelo Towards Glucose Health

Yes

Patrick Welch, PharmD, BCACP

Dr. Welch is an Advanced Clinical Pharmacist specializing in Family Medicine. After graduating from the University of Utah College of Pharmacy, he completed a two year ambulatory care pharmacy residency. Dr. Welch currently works in Family Medicine managing chronic disease states under collaborative practice agreements. He spends most of his time helping people living with diabetes including management of insulin pump therapy and CGM. He enjoys using the latest technology to help patients live their healthiest lives.

Related Resources

Podcast Episode 23: Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes

Premium Content

Off

Podcast Episode 23: Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes

alexa.stelzer — Mon, 13 Jan 2025 18:05:46 +0000

Podcast Episode 23: Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes

02/11/2025

alexa.stelzer Mon, 01/13/2025 - 18:05

Guest Speaker: Emily Cornelius, RDN

Real-time real talk is intended for healthcare professionals in the US.

In this episode of Real Time Real Talk, host Cher Pastore is joined by Registered Dietitian Emily Cornelius to discuss the science behind monitoring glucose levels in individuals with prediabetes and type 2 diabetes. The discussion includes:

Impact of glucose sensors on behavior change
Importance of personalized nutrition plans
Accessibility of glucose sensors without a prescription
Introduction of Dexcom's new product, Stelo

To learn more about Stelo, visit www.Stelo.com .

^MAT-7567

Podcast

Diabetes Technology

Stelo: Personalizing Choices, Revolutionizing Glucose Health

Podcasts

Yes

Related Resources

New Video Series: Your Journey with Stelo Towards Glucose Health

Premium Content

Off

New Video Series: Your Journey with Stelo Towards Glucose Health

alexa.stelzer — Wed, 23 Oct 2024 21:38:18 +0000

New Video Series: Your Journey with Stelo Towards Glucose Health

11/06/2024

alexa.stelzer Wed, 10/23/2024 - 21:38

Help Patients Turn Personalized Glucose Insights Into Action

Staying informed about the latest advancements in glucose sensing technology, including over-the-counter (OTC) options, is crucial for healthcare providers. Equally important is having resources to share with patients, helping them understand and effectively use these technologies.

To support healthcare providers and patients, Dexcom has released a new video series that shares tips and tricks for using Stelo, the first OTC glucose biosensor. The 6-part series features advice from certified diabetes specialists and real-life experiences of Stelo users. View the videos below or click here to access and share the complete Stelo Video Gallery. It is recommended that the videos be viewed in order.

How Stelo Helps You

This introductory video explains how Stelo allows patients to see the impact of food and activity on their glucose levels, empowering them to make healthier choices.

Watch and Learn

A healthcare provider shares recommendations on how to get started with Stelo, including the optimal times to check glucose levels around meals and physical activity.

How to Lower Post-Meal Glucose

Practical tips from Stelo users on making small adjustments to eating habits to maintain healthier post-meal glucose levels.

How Physical Activity Can Affect Your Glucose

Insights into how different types of physical activity impact glucose levels and how to set achievable health goals.

How Sleep and Stress Can Affect Your Glucose

Information on how stress and sleep affect glucose levels and how to use Stelo to make persanolized changes for better sleep and stress management.

Putting It All Together

Users share the most impactful changes Stelo has helped them make, along with discussions on common questions such as why glucose levels might be higher in the morning and what to do when glucose drops below 70.

Learn More About Dexcom's Product Portfolio

For healthcare providers interested in learning more about Dexcom's product portfolio, including Stelo, additional information is available on provider.dexcom.com.

Training Materials

Stelo: Personalizing Choices, Revolutionizing Glucose Health

Related Resources

ATTD 2024 Symposia: CGM Improves Outcomes in Non-Insulin Treated Type 2 Diabetes

Premium Content

Off

Stelo: Personalizing Choices, Revolutionizing Glucose Health Presented by Rachael Sood NP-C, CDCES

alexa.stelzer — Thu, 10 Oct 2024 18:57:07 +0000

Stelo: Personalizing Choices, Revolutionizing Glucose Health Presented by Rachael Sood NP-C, CDCES

10/18/2024

alexa.stelzer Thu, 10/10/2024 - 18:57

Webinar Featuring Rachael Sood RN, MSN, NP-C, CDCES

Watch the recording of Rachael Sood RN, MSN, NP-C, CDCES, as she presents "Stelo: Personalizing Choices, Revolutionizing Glucose Health".

About the Webinar

In this 56-minute session, Rachel Sood, provides an introduction to Stelo and key takeways from the perspective of a Diabetes Nurse Practitioner. Stelo is the first FDA-cleared OTC glucose biosensor and tailored for patients with prediabetes or type 2 diabetes not on insulin.

Key Highlights:

[02:24] The Dexcom portfolio: Discover the differences between Dexcom G7 CGM and Stelo and how to choose the right product for your patients

[11:32] Glucose management matters: Explore why managing glucose levels is important for patients with type 2 diabetes and prediabetes

[20:17] Introducing Stelo: Learn about the innovative functionality of Stelo

[23:46] Case Study: Explore how Stelo impacts decision making and outcomes in a patient with type 2 diabetes

[25:07] Key Stelo features: Deep dive into Stelo's unique features and how they promote behavior change

[47:10] Emerging clinical evidence in T2D: Review recent evidence indicating that glucose monitoring devices can improve diabetes outcomes

[53:32] GLP-1 medications and CGM: Highlights the benefits of using a Dexcom CGM in combination with GLP-1 medications

[54:35] Getting started: Learn how to help patients get started on Stelo

About Stelo by Dexcom

Stelo marks a significant advancement in glucose monitoring. As the first FDA-cleared OTC glucose biosensor, it provides an option for those who do not have insurance coverage for CGM. With Stelo, patients can monitor their glucose levels and target range, enabling informed decisions about their health and lifestyle.

Learn More About Stelo

Don’t miss out on this valuable opportunity to enhance your practice and improve patient care. Learn more at Stelo.com.

^Keywords^{: Stelo, glucose biosensor, glucose monitoring, prediabetes, type 2 diabetes, Dexcom, patient empowerment, primary care, glucose health webinar}

Seeing is Believing: Sustained Behavior Change Powered by Dexcom

Yes

Rachael Sood, RN, MSN, NP-C, CDCES

Rachael Sood, RN, MSN, NP-C, CDCES, is a diabetes nurse practitioner in Mandeville, Louisiana. She is the owner and operator of The Diabetes Collective, the first and only dedicated diabetes clinic in southern Louisiana, providing full-service specialized diabetes care. Ms. Sood’s business was launched in an effort to bring advanced diabetes care to her hometown using direct care models, technology integration, and updated practice tools and techniques that the rural region had never seen. She also serves as a nursing instructor for the Louisiana State University School of Nursing and was honored in 2024 by the Louisiana State Nurses Association as one of the top "40 under 40" trailblazing nurses recognized for revolutionizing patient care, driving innovations, and inspiring their peers. Ms. Sood is board certified by the American Academy of Nurse Practitioners and is a certified diabetes care and education specialist.

Related Resources

Premium Content

Off

Stelo: Personalizing Choices, Revolutionizing Glucose Health

alexa.stelzer — Mon, 16 Sep 2024 18:28:40 +0000

Stelo: Personalizing Choices, Revolutionizing Glucose Health

09/18/2024

alexa.stelzer Mon, 09/16/2024 - 18:28

Webinar Featuring Dr. Thomas Grace, MD, CDCES

Watch the recording of Dr. Thomas Grace, MD, CDCES, as he presents "Stelo: Personalizing Choices, Revolutionizing Glucose Health".

About the Webinar

In this 49-minute session, Dr. Thomas Grace explores the groundbreaking features of Stelo, the first FDA-cleared OTC glucose biosensor. Tailored for patients with prediabetes or type 2 diabetes not on insulin, Stelo empowers patients to track their glucose health with ease.

Key Highlights:

[01:42] The Dexcom portfolio: Glucose management solutions for all stages of the diabetes journey
[11:12] Why glucose management matters: Understand the impact of a glucose sensor on glycemic outcomes
[17:16] Introducing Stelo: Explore the innovative functionality of Stelo
[21:08] Behavior change: See how Stelo can empower people to achieve and maintain health behaviors
[46:54] Getting started: Learn how to get started on Stelo

About Stelo by Dexcom

Stelo marks a significant advancement in glucose monitoring. As the first FDA-cleared OTC glucose biosensor, it provides an option for those who do not have insurance coverage for CGM. With Stelo, patients can monitor their glucose levels and target range, enabling informed decisions about their health and lifestyle.

Learn More About Stelo

Don’t miss out on this valuable opportunity to enhance your practice and improve patient care. Learn more at Stelo.com.

^Keywords^{: Stelo, glucose biosensor, glucose monitoring, prediabetes, type 2 diabetes, Dexcom, patient empowerment, primary care, glucose health webinar}